China is not winning the gene-editing race

• Autores: Michael Le Page
• Localización: New scientist, ISSN 0262-4079, Nº. 3163, 2018, pág. 25
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • At least 86 people have been treated with the CRISPR genome-editing method in China since 2015, according to a recent Wall Street Journal report on these first trials. The WSJ says this means China is racing ahead in gene editing, while the US is being left behind. But this is rather misleading. For starters, the first-ever use of gene editing to treat people was in the US, in 2009. Immune cells were removed from people with HIV, edited outside the body to disable the gene that the virus exploits to infect cells, then returned to the body. The first-ever use of gene editing to cure cancer, meanwhile, was in 2015, in the UK